micro News and Research

RSS

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

A new study evaluated the efficacy of Pfizer’s BNT162b2 vaccine in children aged 17 years or younger after the emergence of the SARS-CoV-2 Omicron variant.

2 Mar 2022

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

Researchers at NOMAD Bioscience GmbH are taking advantage of the remarkable liquid handling capabilities of INTEGRA’s VOYAGER adjustable tip spacing pipette for the preparation and dispensing of media and gels.

From INTEGRA Biosciences 1 Mar 2022

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Researchers evaluated the pathogenicity and replication potential of SARS-CoV-2 VOC Omicron lineage, BA.2 in immunocompetent mice and hamsters.

28 Feb 2022

Children living in greener and less polluted areas have 50% lower risk of developing ADHD

Children living in areas with higher air pollution due to PM2.5 particles and very low levels of green space might have up to 62% increased risk of developing ADHD.

24 Feb 2022

Pre-existing B-cell immunity against SARS-CoV-2 not detected in pre-pandemic samples

A recent study investigates samples solated from unexposed individuals pre-pandemic to determine the presence of pre-existing SARS-CoV-2 B-cell immunity.

22 Feb 2022

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

Researchers explore the potential of mosaic receptor-binding domain nanoparticles in protective immunity against SARS-CoV-2

22 Feb 2022

New research focuses on improving the manufacturing process of lab-grown tissue from cells

Improving the way lab-grown tissue can be generated and organised from cells is the focus of new research from The University of Queensland.

22 Feb 2022

Study explores the decline in viral load and immune response in COVID-19 patients

Researchers described the changes in viral ribonucleic acid the decline in viral load, and the immune response of SARS-CoV-2-infected patients, in a new preprint study.

22 Feb 2022

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Researchers investigate the potential of picolinic acid (PA) as an anti-SARS-CoV-2 treatment option.

21 Feb 2022

Benchmarking models of SARS-CoV-2 transmission through aerosols and droplets

A new study generated a consolidated set of parameters involving the exhalation of particles.

20 Feb 2022

Mechanism of fatty-acid coupled adaptive immunity in SARS-CoV-2 revealed

A new study explains how SARS-CoV-2 adapts its immunogenicity to the immune response of the host.

20 Feb 2022

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Researchers characterized the responses of the PBMCs at the individual cell and cell type levels against SARS-CoV-2 and SARS-CoV ex vivo.

18 Feb 2022

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Researchers recently evaluated the efficacy of the Oxford ChAdOx1 (AZD 1222/ AZD2816) vaccine against the Omicron, Delta, and Beta variants of SARS-CoV-2 in Syrian hamsters.

17 Feb 2022

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

Researchers present a simple and efficient plasmonic-magnetic nanorobot for the detection of SARS-CoV-2 RNA.

16 Feb 2022

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Researchers select and study an RDV-resistant virus by serial passaging of wild type SARS-CoV-2 in the presence of increasing concentrations of RDV.

15 Feb 2022

Neutralizing antibody levels to different SARS-CoV-2 epitopes fluctuate over time

Researchers study antibodies against various SARS-CoV-2 epitopes that may be responsible for neutralizing activities in recovered COVID-19 patients.

15 Feb 2022

New approach to alter the skin microbiome and reduce acne lesions using bacteria

Acne on the face is often treated with topical antibiotics, which tend to be used for an extended period of time and contribute to the serious problem of antibiotic resistance.

15 Feb 2022

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from Toronto, Canada, characterized the markers of endothelial function and developed micro ribonucleic acid (miRNA) expression atlas in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive and -negative patients admitted to the intensive care unit (ICU).

15 Feb 2022

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

A recent study posted to the bioRxiv* pre-print server investigated the antiviral potential of N-acylethanolamine acid amidase (NAAA) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the Zika virus (ZIKV).

14 Feb 2022

Group cell movement could be harnessed to stop cancer spread, study suggests

Cells push and pull on surrounding tissue to move in groups as they form organs in an embryo, track down invading bacteria, and become cancerous and spread.

14 Feb 2022

micro News and Research

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Children living in greener and less polluted areas have 50% lower risk of developing ADHD

Pre-existing B-cell immunity against SARS-CoV-2 not detected in pre-pandemic samples

Exploring the potential of mosaic RBD nanoparticles to fight SARS-CoV-2

New research focuses on improving the manufacturing process of lab-grown tissue from cells

Study explores the decline in viral load and immune response in COVID-19 patients

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Benchmarking models of SARS-CoV-2 transmission through aerosols and droplets

Mechanism of fatty-acid coupled adaptive immunity in SARS-CoV-2 revealed

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

ChAdOx1 vaccine found to protect Syrian hamsters against SARS-CoV-2 variants

Detection of SARS-CoV-2 RNA by plasmonic-magnetic nanorobots

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Neutralizing antibody levels to different SARS-CoV-2 epitopes fluctuate over time

New approach to alter the skin microbiome and reduce acne lesions using bacteria

Cardiovascular markers for predicting clinical outcomes in SARS-CoV-2 infection

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

Group cell movement could be harnessed to stop cancer spread, study suggests

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News